Ball Corporation BALL ← Back to all reports

Ball Corporation

BALL · Materials
B ★★★ Hold
Aug 5, 2026 · Score 84 · Type A — Value-style analysis Used for established, cash-generative companies — weighs earnings power, valuation against the company's own history and peers, and margin of safety. Full methodology →
Current PriceThe market price around the time this report was written — not a live quote. The market has moved since; check a current price before acting.Methodology → $65.15
Buy ZoneThe large figure is the midpoint of the suggested buy range shown in parentheses. $58.00 ($56.00–$60.00)
Target PriceOur estimated fair value. For richly valued stocks it can sit below the current price — see Methodology.Methodology → $71.14
Expected Return
  • Target relative to the Current Price ((Target − Current) ÷ Current). Since that price is from the report date, your actual return will differ.
  • A negative figure isn't an error. For richly valued stocks, the fair-value target can sit below the current price, so the return reads negative. The grade reflects company quality; this figure reflects today's entry valuation.
Methodology →
+9.2%

Type A - Ball Corporation (BALL) 20260805 Stock Analysis

📅 Ball Key Upcoming Events

🏢 Step 1: Ball Company Overview & Business Model

Q1-A1. What is Ball?

Q1-A2. How Does Ball Make Money?

Q1-A3. Ball’s Revenue Segments & Core Income Sources

Q1-A4. Who Are Ball’s Competitors?

Q1-A5. Ball Key Events: Past 12 Months

Q1-A6. Step 1 Key Takeaways

🏰 Step 2: Ball’s Economic Moat, Growth & Capital Allocation

Q2-A1. Does Ball Have a Durable Economic Moat?

Q2-A2. Is Ball’s Growth Sustainable?

Q2-A3. How Does Ball Allocate Capital & Return Cash?

Q2-A4. Step 2 Key Takeaways

💰 Step 3: Is Ball Profitable? Financial Health Analysis

Q3-A2. How Profitable Is Ball? (Margins & ROIC)

Q3-A3. What Drives Ball’s Returns? (ROIC Breakdown)

Q3-A4. Are Ball’s Earnings High Quality?

Q3-A5. Is Ball’s Balance Sheet Healthy? (Debt & Leverage)

Q3-A6. Step 3 Key Takeaways

🔎 Step 4: Ball Forensic Accounting & Dilution Review

Q4-A1. Does Ball Have Accounting Red Flags?

Q4-A2. Is Ball Overspending? (Capex & Capital Cycle)

Q4-A3. How Sound Is Ball’s Cash Flow?

Q4-A4. Is Ball Diluting Shareholders?

Q4-A5. Data Integrity Check

Q4-A6. Step 4 Key Takeaways

👔 Step 5: Ball Management & Shareholder Alignment

Q5-A1. Can You Trust Ball’s Management? (Guidance Track Record)

Q5-A2. What Are Ball Insiders Doing?

Q5-A3. Is Ball’s Management Aligned With Shareholders?

Q5-A4. Step 5 Key Takeaways

⛵ Step 6: Ball Market Flow & Sentiment

Q6-A1. Analyst Consensus vs Ball Guidance

Q6-A2. What Is Ball’s Short Interest?

Q6-A3. Step 6 Key Takeaways

🚀 Step 7: Ball Catalysts & Price Triggers

Q7-A1. What Could Move Ball Stock? (Top 3 Catalysts)

Q7-A2. Ball’s Earnings Revision Trend

Q7-A3. Step 7 Key Takeaways

⚖️ Step 8: Is Ball Fairly Valued? Valuation Analysis

Q8-A1. Ball’s Key Valuation Multiples (P/E, EV/EBITDA)

Q8-A2. Ball vs Peers: Valuation Comparison

Q8-A3. Is Ball Cheap or Expensive vs Its History?

Q8-A4. What Growth Is Priced Into Ball? (Reverse DCF)

Q8-A4-1. What Growth Hurdle Does the Market Demand From Ball? (Reverse DCF Alternative)

Q8-A5. Valuation Cross-Check

Q8-A6. Ball’s Asset & Stake Valuation

Q8-A7. Final Valuation Adjustment

Q8-A8. Valuation Adjustment Score Calculation

💀 Step 9: What Are the Risks of Ball? Fatal Risks & Pre-Mortem

Q9-A1. What Are the Biggest Risks to Ball?

Q9-A2. How Sensitive Is Ball to the Economy?

Q9-A3. Ball Pre-Mortem: What Could Go Wrong?

Q9-A4. Risk Adjustment Score Calculation

🎯 Step 10: Ball Final Verdict: Score & Rating

Q10-A1. Investment Score & Rating

Q10-A2. Should You Buy Ball? (Recommendation)

Q10-A3. Investment Thesis in One Line

Q10-A4. Ball’s Price Trend & Key Drivers

Q10-A5. Action Plan

🕵️‍♂️ Deep Dive Analysis

Q1: Is Ball’s Heavy Revenue Concentration With Beverage Titans Like Coca-Cola and AB InBev Its Biggest Weakness?

Q2: Can Ball’s 16.2x Forward P/E Be Justified Amid Persistent Start-Up Friction at the Millersburg Facility?

Q3: How Does the $150 Million Cost-Savings Program Tangibly Insulate Ball’s Margins Against Inflationary Pressures?

Q4: Will the Expanding Extended Producer Responsibility (EPR) Legislation Structurally Favor Ball Over Plastic Packaging Peers?

Q5: Does the Divestiture of the Aerospace Division Fundamentally De-Risk Ball’s Long-Term Capital Allocation Strategy?

Q6: Can the South American Segment Sustain Its 64% Operating Earnings Surge Despite Emerging Market Macro Volatility?

Q7: How Effectively Does the STARcan Lightweighting Innovation Reduce Ball’s Scope 3 Carbon Emissions and Raw Material Spend?

Q8: Is the $6.7 Billion Debt Load an Existential Threat or a Manageable Friction Point in the Current Restrictive Rate Environment?

Q9: Will the Benepack Acquisition in EMEA Generate Sufficient Volume to Offset Initial Integration Costs by Fiscal 2027?

Q10: Does the Transition from Daniel Fisher to Ronald Lewis Signal a Shift Toward Operational Consolidation Over Aggressive Expansion?